These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9229168)

  • 21. Ursodeoxycholic acid therapy in hepatobiliary disease.
    Kowdley KV
    Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
    Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
    JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extreme short bowel syndrome in a full-term neonate--a case report.
    Heemskerk J; Sie GH; Van den Neucker AM; Forget PP; Heineman E; van Heurn LW
    J Pediatr Surg; 2003 Nov; 38(11):1665-6. PubMed ID: 14614721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
    Kadayifci A; Savas MC; Arslan S; Güllú IH
    J Clin Gastroenterol; 1997 Mar; 24(2):125-6. PubMed ID: 9077736
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parenteral nutrition-associated liver disease].
    Moreno Villares JM
    Nutr Hosp; 2008 May; 23 Suppl 2():25-33. PubMed ID: 18714408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
    Beau P; Labat-Labourdette J; Ingrand P; Beauchant M
    J Hepatol; 1994 Feb; 20(2):240-4. PubMed ID: 8006405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodiol in patients with parenteral nutrition-associated cholestasis.
    San Luis VA; Btaiche IF
    Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
    Mangalat N; Bell C; Graves A; Imseis EM
    BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide.
    Teitelbaum DH; Han-Markey T; Schumacher RE
    J Pediatr Surg; 1995 Jul; 30(7):1082-5. PubMed ID: 7472937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of cholestasis and cholestatic disorders.
    Sanyal A
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C88-9. PubMed ID: 11293189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment of cholestasis.
    Alvaro D
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():47-51. PubMed ID: 8899693
    [No Abstract]   [Full Text] [Related]  

  • 32. Total parenteral nutrition associated cholestasis: a predisposing factor for sepsis in surgical neonates?
    Bos AP; Tibboel D; Hazebroek FW; Bergmeijer JH; van Kalsbeek EJ; Molenaar JC
    Eur J Pediatr; 1990 Feb; 149(5):351-3. PubMed ID: 2107080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Streptococcus pneumoniae-Associated Hemolytic and Uremic Syndrome With Cholestasis: A Case Report and Brief Literature Review.
    Anastaze Stelle K; Cachat F; Perez MH; Chehade H
    Clin Pediatr (Phila); 2016 Feb; 55(2):189-91. PubMed ID: 25848129
    [No Abstract]   [Full Text] [Related]  

  • 34. Total parenteral nutrition cholestasis: a cause of mechanical biliary obstruction.
    Enzenauer RW; Montrey JS; Barcia PJ; Woods J
    Pediatrics; 1985 Dec; 76(6):905-8. PubMed ID: 3934638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholestasis associated with total parenteral nutrition.
    Merritt RJ
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):9-22. PubMed ID: 3080580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report.
    Lindor KD; Burnes J
    Gastroenterology; 1991 Jul; 101(1):250-3. PubMed ID: 1904380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholestasis of pregnancy: ursodeoxycholic acid therapy.
    Javitt NB
    J Hepatol; 1998 Nov; 29(5):827-8. PubMed ID: 9833923
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of ursodeoxycholic acid in liver diseases.
    Kumar D; Tandon RK
    J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenteral nutrition related hepato-biliary disease in adults.
    Raman M; Allard JP
    Appl Physiol Nutr Metab; 2007 Aug; 32(4):646-54. PubMed ID: 17622278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.